Fresenius Medical Care multiFiltrate Instructions For Use Manual page 8

5 Alarm processing
5.1 Acknowledging a message repeatedly.................................................................................... 5-1
5.2 Alarm schemes .......................................................................................................................... 5-2
5.2.1 Old alarm scheme........................................................................................................................ 5-2
5.2.2 New alarm scheme ...................................................................................................................... 5-3
5.3 High-priority alarm conditions ................................................................................................. 5-3
5.4 Monitoring function suppression............................................................................................. 5-4
5.5 Alarm system ............................................................................................................................. 5-4
5.6 Alarm system response ............................................................................................................ 5-6
5.7 Messages.................................................................................................................................... 5-7
5.7.1 Note box (white)........................................................................................................................... 5-8
5.7.2 Warning box................................................................................................................................. 5-8
5.7.3 Alarm box..................................................................................................................................... 5-9
5.8 Messages during the functional test ..................................................................................... 5-10
5.9 Handling alarm limits in the event of an alarm ..................................................................... 5-11
5.10 Ratio of UF rate to BP rate ...................................................................................................... 5-12
5.11 Ratio of calcium flow to filtrate flow ...................................................................................... 5-14
5.12 Ratio of citrate flow to BP rate ............................................................................................... 5-15
5.13 Overriding the blood leak detector ........................................................................................ 5-16
5.14 Power failure (mains failure)................................................................................................... 5-18
5.15 Manual reinfusion .................................................................................................................... 5-19
6 Cleaning / disinfection
6.1 Surface cleaning / surface disinfection ................................................................................... 6-1
6.2 Disinfectants and cleaning agents........................................................................................... 6-1
7 Functional description
7.1 Device functions ........................................................................................................................ 7-1
7.2 Description of treatments ......................................................................................................... 7-2
7.2.1 Continuous renal replacement therapy
(CRRT = Continuous renal replacement therapy) ....................................................................... 7-2
7.2.2 Paediatric CRRT treatments...................................................................................................... 7-10
7.2.3 Membrane plasma separation (MPS) ........................................................................................ 7-11
7.2.4 Slow continuous ultrafiltration (SCUF)....................................................................................... 7-14
7.2.5 Haemoperfusion (HP) ................................................................................................................ 7-15
7.3 Anticoagulation........................................................................................................................ 7-16
7.3.1 Systemic anticoagulation ........................................................................................................... 7-16
7.3.2 Regional anticoagulation with citrate ......................................................................................... 7-17
7.3.2.1
7.3.2.2
viii
General information on citrate anticoagulation ........................................................... 7-17
Adequate anticoagulation in the extracorporeal blood circuit ..................................... 7-22
Fresenius Medical Care multiFiltrate IFU-EN-UK 15A-2015